How does etanercept prevent tumour necrosis factor (TNF) from activating its cell-surface receptors?

Etanercept, a dimeric soluble receptor, is thought to competitively inhibit TNF binding to cell-surface TNF receptors, rendering TNF biologically inactive and preventing TNF-mediated cellular responses.